Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings

Takuji Okusaka, Shuichi Okada, Hideki Ueno, Masafumi Ikeda, Kazuaki Shimada, Junji Yamamoto, Tomoo Kosuge, Susumu Yamasaki, Noriyoshi Fukushima, Michiie Sakamoto

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Abdominal and/or back pain is one of the most common symptoms in patients with pancreatic cancer. However, the cause of the pain and the clinicopathologic features of patients with pain have not been fully elucidated. We retrospectively determined the factors related to preoperative abdominal and/or back pain in 95 patients with resectable pancreatic cancer. Pancreatic tumor size, invasion of the intrapancreatic nerves, invasion of the anterior pancreatic capsule, and lymph node metastasis were determined to be variables related to the pain. Pancreatic tumor size, invasion of anterior pancreatic capsule, and lymph node metastasis were also variables significantly correlating to pain intensity. Survival also correlated with pain intensity: the median survival periods were 29 months in patients without pain, 19 months in those with mild pain, and 9 months in those with severe pain who required analgesics. Larger pancreatic tumors, invasion of the intrapancreatic nerves, and invasion of the anterior pancreatic capsule may cause abdominal and/or back pain in patients with resectable pancreatic cancer. This study also suggests clinical implications of the pain intensity as a prognostic factor in patients with resectable pancreatic cancer.

Original languageEnglish
Pages (from-to)279-284
Number of pages6
JournalPancreas
Volume22
Issue number3
DOIs
Publication statusPublished - 2001
Externally publishedYes

Keywords

  • Abdominal pain
  • Back pain
  • Pancreatic cancer

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Fingerprint

Dive into the research topics of 'Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings'. Together they form a unique fingerprint.

Cite this